CANMAT Guidelines: Bipolar Disorder Part 3 + general Bipolar DSM Flashcards

1
Q

what are the most common comorbid conditions with BD

A

SUB

anxiety

personality disorder

impulse control disorder (ODD, ADHD, CD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the prevalence of SUDs in BD

A

33%-45%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the only treatment for alcohol use disorder co-morbid with BD in the guidelines with level 2 evidence (theres none higher)

A

lithium + divalproex (compared to lithium alone)

*watchout for electrolyte imbalances and liver function issues

theres level 3 and 4 evidence for other tx like disulfiram, naltrexone, gabapentin etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

is quetiapine recommended for treatment of AUD co-morbid with BD

A

no–lack of efficacy shown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what % of people with BD have cannabis use disorder

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what affect does cannabis have on course of BD

A

associated with more time in affective episodes and rapid cycling (as well as a bunch of other stuff like more psychotic features)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what medication showed benefit in treating cocaine use disorder co-morbid with BD

A

citicoline

also lithium and/or divalproex alone or in combo

buprioprion has anecdotal evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which medication has the most evidence of efficacy for treating OUD comorbid with BD

A

methadone

but lack of research in this area and there is concern with risk of overdose so should consult CRISM guidelines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what non-BD related medication may be reasonable to consider using to treat anxiety when comorbid with BD? why this med? do we have evidence for this?

A

pregabalin

effective and not associated with risk of mood destabilization and is well tolerated

not tested in BD population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

list medications that have evidence for treating anxiety symptoms/GAD in those with BD

A

quetiapine

lamotrigine or olanzapine + lithium in those who are euthymic and already on lithium

olanzapine + fluoxetine

gabapentin adjunctive therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

does OCD have higher rates in those with BD compared to the general population

A

yes

*“some researchers have posited that the high rate of co-occurrence might reflect a distinct bipolar phenotype rather than separate disorders.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what % of those with BD also have a co-morbid personality disorder

A

42% per a meta analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what was the most prevalent co-morbid personality disorder with BD

A

obsessive compulsive PD

then borderline, then avoidant, then paranoid, then histrionic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what medications may provide relief for those with borderline PD co-morbid with BD

A

divalproex and lamotrigine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what % of adults with ADHD also meet the criteria for BD

A

up to 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what % of patients with BD also meet criteria for adult ADHD

A

10-20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do you approach treatment of comorbid ADHD and BD

A

treat the mood symptoms first then treat ADHD

reduced risk of mania with use of methylphenidate when treated concurrently with a mood stabilizer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

treatment with lithium was associated with reduced risk of what diseases

A

stroke and cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what baseline lab investigations should be done in patients with bipolar disorder

A

+ prolactin
+pregnancy test (if relevant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what medical monitoring should be done for those on lithium therapy

A

thyroid function
renal function
plasma calcium

–assessed at 6 months then at least annually thereafter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what medical monitoring should be done for those on divalproex therapy

A

menstrual hx (to assess for PCOS)

hematology profile

liver function tests

–assessed at 3-6 month intervals during 1st year then at least annually thereafter

22
Q

what patient education should be done for those on carbamazepine or lamotrigine therapy

A

routine education about risks of skin rashes or potential for stevens johnson syndrome or toxic epidermal necrolysis

patients should contact healthcare professional if develop rash or mucosal ulcers

23
Q

which population should receive genetic screening before starting carbamazepine? why?

A

high risk populations like Han Chinese and other asian populations

make sure do not have human leukocyte antigen (HLA)-B*1502 allele–> confers high risk for SJS/TEN with carbamazepine

24
Q

what medical monitoring should be done for those on carbamazepine therapy

A

serum sodium levels at least annually due to risk of hyponatremia

25
how often should you do serum levels for lithium and divalproex? (note-should also do serum levels of carbamazepine, but just to check adherence)
two consecutive serum trough levels should be established in the acute phase then q3-6 months or more frequently if clinically indicated
26
what is the target serum level in acute treatment for lithium
0.8-1.2mEq/L
27
what is the target serum level for lithium in maintenance treatment
0.6-1mEq/L ("may" be sufficient)
28
how many days after the most recent dose titration should you get a level of lithium
about 5 days
29
what is the target serum level of divalproex in the acute phase of treatment
350-700mM/L (same during acute and maintenance)
30
when should you get a divalproex level after the most recent dose change
3-5 days after
31
can lithium cause weight gain
yes so can divalproex
32
can gabapentin cause weight gain
yes
33
what is the effect of lurasidone on weight gain
minimal
34
what GI side effects are commonly associated with lithium and divalproex
nauseu vomiting diarrhea (35-45% of people experience this) particularly pronounced during lithium initiation or rapid dose increases
35
what % of patients on lithium report nephrogenic diabetes insipidus (NDI)
20-40%
36
what % of patients on lithium will experience polyuria
upwards of 70%
37
what long term effects can lithium have on the kidneys
i.e 10-20+ year admin of lithium can cause: decrease glomerular filtration rate chronic kidney disease (2x increased risk in older adults)
38
what diseases can lithium cause due to renal toxicity
nephrogenic diabetes insipidus chronic tubulointerstitial nephropathy acute tubular necrosis
39
when should you consult nephrology for your patient on lithium
if rapidly declining eGFR if eGFR falls below 45 in two consecutive readings if clinician is concerned
40
can lithium cause QT prolongation
yes
41
why do you screen for serum calcium in people on lithium
because lithium can cause hyperparathyroidism and serum calcium screens for this if serum Ca elevated--> further investigate
42
is hypothyroidism an indication for lithium cessation in a patient who has responded well to lithium
no not normally--> recommend thyroid supplementation instead
43
what 3 APs are more likely to cause hyperprolactinemia
risperidone paliperidone amisulpride
44
how might hyperprolactinemia persent
amenorrhea sexual dysfunction galactorrhea gynecomastia osteoporosis
45
is lithium, lamotrigine or divalproex most likely to cause sedation
divalproex
46
tremor is experiences by what % of those on lithium or divalproex
10%
47
what should you rule out if your patient on divalproex presents with new onset neurological symptoms
hyperammonemic encephalopathy can be fatal
48
what % of patients being treated with lamotrigine will experience a non-serious rash
10%
49
what % of patients being treated with lamotrigine will experience a serious rash like TEN or SJS
0.3-1% risk MUCH lower with starting dose of 25mg and slow titration
50
what skin conditions can be associated with lithium treatment
acne, psoriasis, eczema, hair loss, hidradenitis suppurativa, nail dystrophy and mucosal lesions overall estimates ranging from 3% to 45% depending on the criteria applied most cases can be managed without treatment discontinuation
51
based on DSM V, is bipolar II still considered to be a "milder" form of bipolar I?
no--> this is because of the amount of time individuals with this condition spend in depression + because instability of mood w bipolar II typically accompanied by SERIOUS IMPAIRMENT in work and social functioning